Lista de obras -

A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan

artículo científico publicado en 2010

A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy

artículo científico publicado en 2018

Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin

artículo científico publicado en 2013

Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancer

artículo científico publicado en 2016

Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.

artículo científico publicado en 2015

Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study

artículo científico publicado en 2016

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

artículo científico publicado en 2007

Clinical management of women with metastatic breast cancer: a descriptive study according to age group.

artículo científico publicado en 2006

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

artículo científico publicado en 2018

Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologists

artículo científico publicado en 2015

Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey

artículo científico publicado en 2016

Does long-term survival exist in pancreatic adenocarcinoma?

artículo científico publicado en 2015

Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial

artículo científico publicado en 2017

First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CR

artículo científico publicado en 2021

First-line treatment strategies for elderly patients with metastatic colorectal cancer

artículo científico publicado en 2007

Impact of chemotherapy on health status and symptom burden of colon cancer survivors: A population-based study ⬇️

artículo científico publicado el 29 de marzo de 2011

Information provision and patient reported outcomes in patients with metastasized colorectal cancer: results from the PROFILES registry.

artículo científico publicado en 2013

Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality Treatment

artículo científico publicado en 2016

Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival

artículo científico publicado en 2014

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

artículo científico publicado en 2015

Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the Netherlands.

artículo científico publicado en 2013

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

artículo científico publicado en 2015

Palliative chemotherapy for patients with synchronous metastases of small-bowel adenocarcinoma: A reflection of daily practice

artículo científico publicado en 2019

Paraganglioma of the uterus. A case report and review of literature.

artículo científico publicado en 2011

Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment

artículo científico publicado en 2009

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, r

artículo científico publicado en 2019

Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old woman

artículo científico publicado en 2017

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study

scientific article published on 06 December 2019

Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

scientific article published on October 2016

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Gr

artículo científico publicado en 2005

Prognostic factors for medium- and long-term survival of esophageal cancer patients in the Netherlands

artículo científico publicado en 2014

Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

artículo científico publicado en 2011

Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study

artículo científico publicado en 2006

Prospectively measured lifestyle factors and BMI explain differences in health-related quality of life between colorectal cancer patients with and without comorbid diabetes.

artículo científico publicado en 2015

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

artículo científico publicado en 2009

Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer

artículo científico publicado en 2008

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, pha

artículo científico publicado en 2019

Salvage endoscopic resection in patients with esophageal adenocarcinoma after chemoradiotherapy

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

artículo científico publicado en 2007

Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon

artículo científico publicado en 2017

T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.

artículo científico publicado en 2011

Ten weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands.

artículo científico publicado en 2014

The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.

artículo científico publicado en 2015

The impact of age on first-line systemic therapy in patients with metachronous metastases from colorectal cancer

artículo científico publicado en 2016

The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years

artículo científico publicado en 2007

The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis

scientific article published on 27 September 2016

Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort

artículo científico publicado en 2020

Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands

artículo científico publicado en 2016

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

scientific article published on 29 January 2019

Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel ⬇️

artículo científico publicado el 19 de enero de 2011

Lista de obras de

A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan

A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy

Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin

Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancer

Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.

Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

Clinical management of women with metastatic breast cancer: a descriptive study according to age group.

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologists

Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey

Does long-term survival exist in pancreatic adenocarcinoma?

Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial

First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CR

First-line treatment strategies for elderly patients with metastatic colorectal cancer

Impact of chemotherapy on health status and symptom burden of colon cancer survivors: A population-based study ⬇️

Information provision and patient reported outcomes in patients with metastasized colorectal cancer: results from the PROFILES registry.

Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality Treatment

Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the Netherlands.

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Palliative chemotherapy for patients with synchronous metastases of small-bowel adenocarcinoma: A reflection of daily practice

Paraganglioma of the uterus. A case report and review of literature.

Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, r

Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old woman

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study

Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Gr

Prognostic factors for medium- and long-term survival of esophageal cancer patients in the Netherlands

Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study

Prospectively measured lifestyle factors and BMI explain differences in health-related quality of life between colorectal cancer patients with and without comorbid diabetes.

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, pha

Salvage endoscopic resection in patients with esophageal adenocarcinoma after chemoradiotherapy

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon

T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.

Ten weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands.

The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.

The impact of age on first-line systemic therapy in patients with metachronous metastases from colorectal cancer

The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years

The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis

Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort

Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel ⬇️